This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser.
Print Document
View Excel Document
Cover
Cover Page
Financial Statements
Condensed Consolidated Balance Sheets (Unaudited)
Condensed Consolidated Balance Sheets (Unaudited) (Parenthetical)
Condensed Consolidated Statements of Operations (Unaudited)
Condensed Consolidated Statements of Comprehensive Loss (Unaudited)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited)
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) (Parenthetical)
Condensed Consolidated Statements of Cash Flows (Unaudited)
Notes to Financial Statements
The Company and a Summary of its Significant Accounting Policies
Balance Sheet Details
Stockholders' Equity
Leases, Commitments and Contingencies
Related Party Transactions
Subsequent Events
Accounting Policies
The Company and a Summary of its Significant Accounting Policies (Policies)
Notes Tables
The Company and a Summary of its Significant Accounting Policies (Tables)
Balance Sheet Details (Tables)
Stockholders' Equity (Tables)
Leases, Commitments and Contingencies (Tables)
Notes Details
The Company and a Summary of its Significant Accounting Policies - Additional Information (Details)
The Company and a Summary of its Significant Accounting Policies - Summary of Reconciliation of Cash, Cash Equivalents and Restricted Cash (Details)
The Company and a Summary of its Significant Accounting Policies - Schedule of Revenues Disaggregated by Revenue Source (Details)
The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Details)
The Company and a Summary of its Significant Accounting Policies - Summary of Percentages of Total Revenue or Accounts Receivable for Third Party Payers and Pharmaceutical Customers (Parenthetical) (Details)
The Company and a Summary of its Significant Accounting Policies - Additional Information (Details 1)
The Company and a Summary of its Significant Accounting Policies - Summary of Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)
The Company and a Summary of its Significant Accounting Policies - Assumptions Used to Calculate Fair Value of Warrant Liability Using Black-Scholes-Merton Valuation Model (Details)
The Company and a Summary of its Significant Accounting Policies - Summary of Changes in Fair Value of Level 3 Liabilities (Details)
Balance Sheet Details - Schedule of Short-Term Marketable Securities (Details)
Balance Sheet Details - Additional Information (Details)
Balance Sheet Details - Schedule of Prepaid Expenses and PP&E (Details)
Balance Sheet Details - Schedule of Accrued Compensation and Accrued Liabilities (Details)
Stockholders' Equity - Additional Information (Details)
Stockholders' Equity - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Details)
Stockholders' Equity - Assumptions Used to Determine Fair Value of Each Option on Date of Grant Issued (Parenthetical) (Details)
Stockholders Equity - Summary of Common Stock Reserved for Future Issuance (Detail)
Stockholders Equity - Summary of Common Stock Reserved for Future Issuance (Parenthetical) (Details)
Leases, Commitments and Contingencies - Additional Information (Details)
Leases, Commitments and Contingencies - Schedule of Long Term Finance Lease Obligations (Details)
Leases, Commitments and Contingencies - Components of Lease Expense (Details)
Leases, Commitments and Contingencies - Schedule of Future Minimum Lease Payments Under Operating and Financing Leases (Details)
Related Party Transactions - Additional Information (Details)
Subsequent Events - Additional Information (Details)
All Reports